Based on histological assessment, including cytological characteristics (mitotic activity, anisokaryosis, cytoplasm inclusions) and expression of at least one of the HCC markers (glypican-3, GS, or both), 12 of 13 tumors were classified as well-differentiated HCC (Fig. 7G). This evidence concerns the gene GPC3 and hepatocellular carcinoma.